Coimbra Protocol Panel
- $1,104.64
- $299
- Save: 72.93%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: ALB, Albumin ALB
Albumin
Also known as: BUNCreatinine Ratio
Bun/Creatinine Ratio
Creatinine
Egfr African American
Egfr Non-Afr. American
Urea Nitrogen (Bun)
Also known as: Calcium 24Hour Urine without Creatinine
Calcium, 24 Hour Urine
Total Volume
Also known as: Calcium Ionized
Calcium, Ionized
Ferritin
Also known as: Inorganic Phosphate, P, Phosphate as Phosphorus, Phosphorus, PO4
Phosphate (As Phosphorus)
Also known as: Phosphate 24 Hour Urine WCreatinine
Creatinine, 24 Hour Urine
Phosphate, 24 Hour Urine
Phosphate/Creat Ratio
Total Volume
Also known as: "Biointact" PTH and Calcium, Intact PTH and Calcium, Parathyroid Hormone and Calcium, PTH and Calcium, PTH Intact and Calcium
Calcium
PARATHYROID HORMONE,
Vitamin D, 25-Oh, D2
Vitamin D, 25-Oh, D3
Vitamin D, 25-Oh, Total
Also known as: Free T4, FT4, T4 Free
T4, Free
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
TSH
The Coimbra Protocol Panel panel contains 11 tests with 22 biomarkers .
Coimbra Protocol Panel: Comprehensive Overview
The Coimbra Protocol Panel is a specialized set of laboratory tests designed to assess various biochemical and physiological markers essential for monitoring patients undergoing high-dose vitamin D therapy. This protocol is primarily utilized for patients with autoimmune disorders, particularly multiple sclerosis, and other chronic inflammatory conditions. The panel provides a detailed evaluation of kidney function, calcium metabolism, phosphate balance, iron storage, and thyroid function. By examining these key biomarkers, healthcare professionals can tailor high-dose vitamin D therapy to optimize patient outcomes while mitigating potential risks such as hypercalcemia and kidney dysfunction.
When and Why the Coimbra Protocol Panel May Be Ordered
The Coimbra Protocol Panel is typically ordered for individuals who are either beginning or currently undergoing high-dose vitamin D therapy as part of the Coimbra Protocol. This protocol, pioneered by Dr. Cicero Coimbra, is based on the concept that autoimmune diseases may be linked to vitamin D resistance. High-dose vitamin D is administered to modulate the immune system, reduce inflammation, and improve disease outcomes. However, because excessive vitamin D can lead to complications such as hypercalcemia, kidney damage, and imbalances in phosphate metabolism, regular monitoring is crucial.
Healthcare providers order this panel to ensure that the patient’s kidney function remains stable, calcium and phosphate levels are maintained within a safe range, and thyroid function is not adversely affected by the therapy. Additionally, the panel assesses iron storage levels, as ferritin plays a role in immune function and overall metabolic health. By closely monitoring these biomarkers, providers can adjust vitamin D dosage, recommend dietary modifications, and implement supportive treatments as needed.
What the Coimbra Protocol Panel Checks For
The Coimbra Protocol Panel evaluates multiple physiological processes, including kidney function, calcium homeostasis, phosphate regulation, vitamin D status, and thyroid function. Each test provides critical insights that help guide treatment decisions.
Kidney Function
Kidney function is assessed through markers such as albumin, urea nitrogen, and creatinine. The kidneys play a vital role in filtering waste products, maintaining electrolyte balance, and regulating calcium and phosphate excretion. Elevated urea nitrogen or creatinine levels may indicate impaired kidney function, which is a crucial consideration when administering high-dose vitamin D, as excessive calcium levels can place strain on the kidneys. Albumin levels provide additional insight into kidney health, as low levels may indicate protein loss due to kidney dysfunction.
Calcium Metabolism
Calcium homeostasis is a central concern in high-dose vitamin D therapy, making the measurement of ionized calcium, total calcium, and 24-hour urine calcium essential. Ionized calcium represents the biologically active form of calcium in the bloodstream, whereas total calcium includes both bound and unbound calcium. Monitoring both ensures that calcium levels remain within a safe range. Excess calcium can lead to symptoms such as kidney stones, calcification of soft tissues, and neurological disturbances. Additionally, measuring 24-hour urine calcium helps assess whether the kidneys are excreting excess calcium appropriately or if there is a risk of hypercalciuria, which can indicate impending kidney stress or damage.
Phosphate Balance
Phosphate metabolism is closely linked to vitamin D and calcium regulation. The panel includes measurements of serum phosphate and 24-hour urine phosphate. Vitamin D plays a role in phosphate absorption, and imbalances can lead to bone demineralization or ectopic calcification. Monitoring phosphate levels ensures that vitamin D therapy is not causing an abnormal phosphate retention or loss, which could have detrimental effects on bone health and overall metabolic function.
Vitamin D Status
Vitamin D total with D2 and D3 quantifies the levels of circulating vitamin D in its different forms. Vitamin D2 is typically derived from plant sources and supplements, while vitamin D3 is synthesized in the skin and obtained from animal sources. This test helps determine whether vitamin D levels are within the desired therapeutic range for the Coimbra Protocol. Since patients on this protocol receive exceptionally high doses, ensuring that levels are neither deficient nor excessively high is critical for preventing toxicity.
Thyroid Function
The thyroid panel within the Coimbra Protocol Panel includes T4 Free and TSH (thyroid-stimulating hormone). These tests assess thyroid function, which can be influenced by high-dose vitamin D therapy. T4 Free represents the active form of thyroxine, which is essential for metabolism and overall endocrine balance. TSH is produced by the pituitary gland and regulates thyroid hormone production. Since thyroid dysfunction can mimic some symptoms of vitamin D toxicity, monitoring these markers ensures that symptoms are correctly attributed to their underlying cause rather than misinterpreted.
How Healthcare Professionals Use the Results of the Coimbra Protocol Panel
Healthcare professionals use the Coimbra Protocol Panel results to guide treatment decisions, adjust vitamin D dosages, and mitigate potential side effects. If kidney function markers such as creatinine or urea nitrogen are elevated, physicians may lower the vitamin D dose or recommend increased hydration to support renal clearance. Elevated calcium levels may prompt dietary modifications, increased fluid intake, or the use of calcium-lowering agents. Conversely, if calcium levels are too low, vitamin D dosing may be increased cautiously to achieve the desired immunomodulatory effect.
Phosphate balance results are carefully reviewed to prevent complications such as bone demineralization or ectopic calcification. If phosphate levels are too high, dietary restrictions or phosphate binders may be considered. For patients with suboptimal vitamin D levels despite high-dose therapy, absorption issues or genetic factors may be explored.
Thyroid function tests help differentiate between symptoms caused by vitamin D imbalances and those resulting from thyroid disorders. If abnormal TSH or T4 Free levels are detected, further endocrinological evaluation may be required to rule out thyroid disease or adjust vitamin D therapy accordingly.
Conclusion
The Coimbra Protocol Panel is an essential tool for safely managing high-dose vitamin D therapy in patients with autoimmune and chronic inflammatory conditions. By evaluating kidney function, calcium metabolism, phosphate regulation, vitamin D status, and thyroid function, this panel ensures that therapy remains effective while minimizing potential risks. Healthcare providers rely on this panel to make informed decisions, adjust treatment plans, and optimize patient outcomes. With proper monitoring and interpretation, the Coimbra Protocol can be administered safely, allowing patients to reap the full benefits of vitamin D therapy while safeguarding against complications.